Medicare Enrolled
Dr. George Kinzfogl, MD
Cardiovascular Disease · Framingham, MA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kinzfogl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kinzfogl?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kinzfogl
Dr. George Kinzfogl is a cardiovascular disease specialist in Framingham, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kinzfogl performed 4,038 Medicare services across 2,542 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kinzfogl received a total of $2,163 from 24 pharmaceutical and/or device companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kinzfogl is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in MA
$2,163 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,038
Medicare services
Top 15% in MA for cardiovascular disease
2,542
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~202 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
859 | $12 | $53 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
738 | $142 | $530 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
369 | $4 | $11 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
320 | $131 | $681 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
305 | $7 | $28 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
176 | $45 | $113 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
160 | $10 | $40 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
149 | $17 | $71 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
138 | $95 | $392 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
122 | $104 | $381 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
99 | $58 | $235 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
93 | $99 | $301 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
67 | $338 | $1,504 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
63 | $64 | $210 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $141 | $586 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
28 | $91 | $344 |
| New patient office visit, complex (60-74 min) | 25 | $171 | $648 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
24 | $22 | $103 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
23 | $88 | $476 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
23 | $12 | $49 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $63 | $269 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
21 | $18 | $74 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
20 | $161 | $1,279 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
19 | $20 | $97 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
17 | $11 | $59 |
| MRI of heart with and without contrast A magnetic resonance imaging scan of the heart performed both before and after the administration of a contrast dye to enhance image detail. |
16 | $94 | $496 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
15 | $22 | $107 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $42 | $113 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
13 | $83 | $822 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $101 | $400 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
12 | $42 | $1,232 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
12 | $11 | $59 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
12 | $58 | $278 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.9% high complexity
14.3% medium
77.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,163
Total received (2018-2024)
Avg $309/year across 7 years
Top 45% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
99
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,149 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$279
2023
$267
2022
$73
2021
$137
2020
$75
2019
$431
2018
$901
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$113
LANTHEUS MEDICAL IMAGING, INC.
$57
Medtronic, Inc.
$33
Novartis Pharmaceuticals Corporation
$27
Novo Nordisk Inc
$18
SCPHARMACEUTICALS INC.
$18
Terumo Medical Corporation
$14
Top 3 companies account for 72.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$502
Amgen Inc.
$298
Novartis Pharmaceuticals Corporation
$260
Lantheus Medical Imaging, Inc.
$220
E.R. Squibb & Sons, L.L.C.
$142
Medtronic, Inc.
$90
PFIZER INC.
$69
SANOFI-AVENTIS U.S. LLC
$68
AstraZeneca Pharmaceuticals LP
$58
LANTHEUS MEDICAL IMAGING, INC.
$57
Gilead Sciences, Inc.
$54
GE HealthCare
$45
Novo Nordisk Inc
$43
Regeneron Healthcare Solutions, Inc.
$39
Janssen Biotech, Inc.
$30
Esperion Therapeutics, Inc.
$28
Chiesi USA, Inc.
$28
Alnylam Pharmaceuticals Inc.
$26
Terumo Medical Corporation
$25
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$19
Kiniksa Pharmaceuticals, Ltd.
$18
SCPHARMACEUTICALS INC.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
CHIESI USA, INC.
$11
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
Arcalyst · Arctic Front · BRILINTA · CAMZYOS · CARDENE · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · Corlanor · DEFINITY · Definity · ELIQUIS · ENTRESTO · FARXIGA · FUROSCIX · GLIDEWIRE · GlideWire · LEQVIO · LINQ II · LifeVest · NEXLETOL · ONPATTRO · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · SYMTUZA · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
588
Per 100K population
36.2
County median income
$126,779
Nearest hospital
METROWEST MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kinzfogl is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 15% in MA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kinzfogl experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Kinzfogl performed 859 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kinzfogl receive payments from pharmaceutical companies?
Yes. Dr. Kinzfogl received a total of $2,163 from 24 companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kinzfogl's costs compare to other cardiologists in Framingham?
Dr. Kinzfogl's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kinzfogl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Framingham
Browse cardiologists in Framingham ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology